Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats (Q28587110)

31 January 2017

title

Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats (English)

1 reference

Marie-Françoise Chesselet

31 January 2017

0 references

1 reference

GOA release 2020-03-11

author

5

object named as

Marie-Françoise Chesselet

1 reference

31 January 2017

Liliana B. Menalled

1

1 reference

31 January 2017

Jessica D. Sison

2

1 reference

31 January 2017

Ioannis Dragatsis

3

1 reference

31 January 2017

Scott Zeitlin

4

1 reference

31 January 2017

language of work or name

English

0 references

publication date

6 October 2003

1 reference

The Journal of Comparative Neurology

31 January 2017

published in

1 reference

31 January 2017

volume

465

1 reference

31 January 2017

issue

1

1 reference

31 January 2017

page(s)

11–26

1 reference

Alternative excitotoxic hypotheses

31 January 2017

cites work

1 reference

7 January 2021

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

1 reference

7 January 2021

Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length

1 reference

7 January 2021

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice

1 reference

7 January 2021

Odor identification in Huntington's disease patients and asymptomatic gene carriers

1 reference

7 January 2021

NMDA receptor function in mouse models of Huntington disease

1 reference

7 January 2021

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene

1 reference

7 January 2021

Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons

1 reference

7 January 2021

Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.

1 reference

7 January 2021

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

1 reference

7 January 2021

Regional and laminar density of the dopamine innervation in adult rat cerebral cortex

1 reference

7 January 2021

Excitotoxic injury of the neostriatum: a model for Huntington's disease

1 reference

7 January 2021

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

1 reference

7 January 2021

Catecholamine innervation of the basal forebrain III. Olfactory bulb, anterior olfactory nuclei, olfactory tubercle and piriform cortex

1 reference

7 January 2021

Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex

1 reference

7 January 2021

Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization

1 reference

7 January 2021

Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection

1 reference

7 January 2021

Substantia nigra lesion protects against ischemic damage in the striatum

1 reference

7 January 2021

Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract

1 reference

7 January 2021

Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.

1 reference

7 January 2021

Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease

1 reference

7 January 2021

Odor detection, learning, and memory in Huntington's disease

1 reference

7 January 2021

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections

1 reference

7 January 2021

Intrastriatal injection of dopamine results in DNA damage and apoptosis in rats

1 reference

7 January 2021

Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease

1 reference

7 January 2021

Neuronal cell death in Huntington's disease: a potential role for dopamine

1 reference

7 January 2021

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice

1 reference

7 January 2021

Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice

1 reference

7 January 2021

Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages.

1 reference

7 January 2021

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

7 January 2021

Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice

1 reference

7 January 2021

Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity

1 reference

7 January 2021

Neurological abnormalities in a knock-in mouse model of Huntington's disease

1 reference

7 January 2021

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

1 reference

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

7 January 2021

Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes

1 reference

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

7 January 2021

Toxicity of Dopamine to Striatal Neurons In Vitro and Potentiation of Cell Death by a Mitochondrial Inhibitor

1 reference

7 January 2021

Mouse models of Huntington's disease

1 reference

7 January 2021

Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease

1 reference

7 January 2021

Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases

1 reference

7 January 2021

Olfactory function in Huntington's disease patients and at-risk offspring

1 reference

7 January 2021

Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment.

1 reference

7 January 2021

Sensory- and memory-mediated olfactory dysfunction in Huntington's disease

1 reference

7 January 2021

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

1 reference

7 January 2021

Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration

1 reference

7 January 2021

Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA.

1 reference

7 January 2021

Differential loss of striatal projection neurons in Huntington disease

1 reference

7 January 2021

Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).

1 reference

7 January 2021

Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis

1 reference

7 January 2021

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

7 January 2021

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin

1 reference

7 January 2021

Motor disorder in Huntington's disease begins as a dysfunction in error feedback control.

1 reference

7 January 2021

Morphometric analysis of the prefrontal cortex in Huntington's disease

1 reference

7 January 2021

Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression

1 reference

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

7 January 2021

Stereotaxic mapping of the monoamine pathways in the rat brain

1 reference

7 January 2021

Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice

1 reference

7 January 2021

A rare case of acoustic neuroma extending from the cerebellopontine angle to the external auditory canal

1 reference

7 January 2021

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

1 reference

7 January 2021

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

1 reference

7 January 2021

Glutamine repeats and neurodegeneration

1 reference

7 January 2021

Identifiers

DOI

10.1002/CNE.10776

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017